GlassScriptPhysician profile
Alex Espana
NPI 1922721091
$10,493.88
in general payments reported to CMS, 2019-2025
29 companies · $3,561 in 2025
The $3,561 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,044 · 2023: $2,592 · 2024: $3,297 · 2025: $3,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,763 · Education: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,762.86 |
| Education | $686.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,519.50 | 2022-2025 | |
| Janssen Biotech, INC. | $1,130.93 | 2022-2025 | Tremfya, Stelara, Simponi |
| Sun Pharmaceutical Industries INC. | $846.28 | 2023-2025 | Winlevi, Ilumya, Absorica Ld |
| E.R. Squibb & Sons, L.L.C. | $745.05 | 2022-2025 | Sotyktu |
| Pfizer INC. | $718.62 | 2022-2025 | |
| Incyte Corporation | $672.43 | 2022-2025 | Opzelura |
| Genzyme Corporation | $586.88 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $557.11 | 2022-2025 | Dupixent, Libtayo |
| Amgen INC. | $556.34 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $522.53 | 2023-2025 | |
| Lilly USA, LLC | $371.98 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $337.74 | 2022-2025 | Bimzelx, Cimzia |
| Leo Pharma INC. | $285.52 | 2022-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $276.26 | 2024-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $269.84 | 2023-2025 | Zoryve |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.60 | 2023-2024 | Spevigo, Cyltezo |
| Sanofi-Aventis U.S. LLC | $179.98 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $132.50 | 2023-2025 | Jublia, Cabtreo, Arazlo |
| Allergan, INC. | $125.01 | 2022 | |
| Merz North America, INC. | $85.56 | 2022-2023 | |
| Organon LLC | $70.13 | 2025 | Vtama |
| Dermavant Sciences, INC. | $69.94 | 2023-2024 | Vtama |
| Almirall LLC | $60.29 | 2024-2025 | Seysara, Klisyri |
| Medtronic, INC. | $43.22 | 2024 | Sinuva |
| Verrica Pharmaceuticals INC. | $37.02 | 2023-2025 | Ycanth |
| Genentech USA, INC. | $34.58 | 2024 | Erivedge |
| Aerin Medical INC. | $33.87 | 2024 | |
| Revance Therapeutics, INC. | $26.27 | 2024 | Daxxify |
| Botanix Sb INC | $17.90 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Espana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.